Cargando…

An updated systematic review and meta-analysis on efficacy of Sofosbuvir in treating hepatitis C-infected patients with advanced chronic kidney disease

Sofosbuvir seems to be a revolutionary treatment for Hepatitis C-infected patients with advanced chronic kidney disease (CKD) but existing evidence is not quite adequate. The aim of this study was to evaluate the efficacy and safety of Sofosbuvir-based therapy without Ribavirin for all hepatitis C v...

Descripción completa

Detalles Bibliográficos
Autores principales:	Majd Jabbari, Sara, Maajani, Khadije, Merat, Shahin, Poustchi, Hossein, Sepanlou, Sadaf G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7875415/ https://www.ncbi.nlm.nih.gov/pubmed/33566846 http://dx.doi.org/10.1371/journal.pone.0246594

Ejemplares similares

The Impact of Illicit Drug Use on Spontaneous Hepatitis C Clearance: Experience from a Large Cohort Population Study
por: Poustchi, Hossein, et al.
Publicado: (2011)

Upper Normal Limits of Serum Alanine Aminotransferase in Healthy Population: A Systematic Review
por: Kolahdoozan, Shadi, et al.
Publicado: (2020)

Clinical Features and Long Term Outcome of 102 Treated Autoimmune Hepatitis Patients
por: Malekzadeh, Zinab, et al.
Publicado: (2012)

Development, validation, and implementation of a Short Breast Health Perception Questionnaire
por: Alipour, Sadaf, et al.
Publicado: (2022)

Infertility Does Not Increase the Rate of Breast Fibroadenoma
por: Motamedi, Mandana, et al.
Publicado: (2023)

Efficacy and safety of sofosbuvir-based antiviral therapy to treat hepatitis C virus infection after kidney transplantation
por: Reddy, Suresh, et al.
Publicado: (2018)

Metformin in Nonalcoholic Steatohepatitis: A Randomized Controlled Trial
por: Kazemi, Rozana, et al.
Publicado: (2012)

Comparative Antiviral Efficacy of Generic Sofosbuvir versus Brand Name Sofosbuvir with Ribavirin for the Treatment of Hepatitis C
por: Tang, L., et al.
Publicado: (2018)

Efficacy and safety of sofosbuvir and daclatasvir in treatment of kidney transplantation recipients with hepatitis C virus infection
por: Xue, Yan, et al.
Publicado: (2017)

Evaluation of the association of endometriosis and mammographic breast density, a cross-sectional study
por: Moini, Ashraf, et al.
Publicado: (2022)

The Presence of Autoantibodies to Cytoplasmic Rod and Ring Particles in the Serum of Patients with Chronic Hepatitis C Virus Infection
por: Afsharzadeh, Fatemeh, et al.
Publicado: (2016)

Sofosbuvir–velpatasvir and sofosbuvir–velpatasvir–voxilaprevir: novel treatment options for naïve and previously treated hepatitis C infection
por: Shin, Hyun Phil
Publicado: (2023)

Cost-Effectiveness of Treating Hepatitis C with Sofosbuvir/Ledipasvir in Germany
por: Stahmeyer, Jona T., et al.
Publicado: (2017)

Residency training amid the COVID-19 pandemic: exploring the impact on mental health and training, a lesson from Iran
por: Moini, Ashraf, et al.
Publicado: (2021)

Efficacy and safety of sofosbuvir–velpatasvir and sofosbuvir–velpatasvir–voxilaprevir for hepatitis C in Korea: a Phase 3b study
por: Heo, Jeong, et al.
Publicado: (2023)

Effects of supplementation with main coffee components including caffeine and/or chlorogenic acid on hepatic, metabolic, and inflammatory indices in patients with non-alcoholic fatty liver disease and type 2 diabetes: a randomized, double-blind, placebo-controlled, clinical trial
por: Mansour, Asieh, et al.
Publicado: (2021)

A Population-based Seroepidemiological Study on Hepatitis E Virus in Iran
por: Sepanlou, SG, et al.
Publicado: (2010)

Impaired HDL cholesterol efflux capacity in patients with non-alcoholic fatty liver disease is associated with subclinical atherosclerosis
por: Fadaei, Reza, et al.
Publicado: (2018)

Rapid reductions in prices for generic sofosbuvir and daclatasvir to treat hepatitis C
por: Hill, Andrew, et al.
Publicado: (2016)

Assessment of auditory functions in chronic hepatitis C patients treated by sofosbuvir
por: Ismail, Elshahat Ibrahem, et al.
Publicado: (2018)

Efficacy of Adding Metformin to Pegylated Interferon and Ribavirin in Treatment Naïve Patients with Chronic Hepatitis C: A Randomized Double-Blind Controlled Trial
por: Sharifi, Amir Houshang, et al.
Publicado: (2014)

Sofosbuvir/velpatasvir/voxilaprevir for hepatitis C
Publicado: (2019)

Efficacy of generic sofosbuvir with daclatasvir compared to sofosbuvir/ledipasvir in genotype 4 hepatitis C virus: A prospective comparison with historical control
por: Joharji, Hala, et al.
Publicado: (2022)

Gender Differences in Healthy Ranges for Serum Alanine Aminotransferase Levels in Adolescence
por: Poustchi, Hossein, et al.
Publicado: (2011)

Hemodialysis Patients Treated for Hepatitis C Using a Sofosbuvir-based Regimen
por: Agarwal, Sanjay Kumar, et al.
Publicado: (2017)

Ledipasvir/Sofosbuvir Effectively Treats Hepatitis C Virus Infections in an Underserved Population
por: Stewart, Rachel A., et al.
Publicado: (2018)

Quality of life of Japanese patients with chronic hepatitis C treated with ledipasvir and sofosbuvir
por: Younossi, Zobair M., et al.
Publicado: (2016)

Trend of Gastrointestinal and Liver Diseases in Iran: Results of the Global Burden of Disease Study, 2010
por: Sepanlou, Sadaf Ghajarieh, et al.
Publicado: (2015)

Burden of Gastrointestinal and Liver Diseases in Iran: Estimates Based on the Global Burden of Disease, Injuries, and Risk Factors Study, 2010
por: Malekzadeh, Fatemeh, et al.
Publicado: (2015)

Efficacy and Safety of Sofosbuvir and Ledipasvir for Hepatitis C in Kidney Transplant Recipients: A Single-center Retrospective Observational Study
por: Artan, Ayşe Serra, et al.
Publicado: (2023)

Development and Application of an In-house Line Probe Assay for Hepatitis C Virus Genotyping
por: Majidzadeh-A, Keivan, et al.
Publicado: (2013)

The burden of road traffic injuries in the northeast of Iran: the result of a population-based registry
por: Khatibi, Seyed Reza, et al.
Publicado: (2020)

Prevalence of Hepatitis B and C Infections and Associated Risk Factors in Pars Cohort Study, Southern Iran
por: Hariri, Sanam, et al.
Publicado: (2021)

Initial results of efficacy and safety of Sofosbuvir among Pakistani Population: A real life trial - Hepatitis Eradication Accuracy Trial of Sofosbuvir (HEATS)
por: Azam, Zahid, et al.
Publicado: (2017)

Treatment of chronic hepatitis C in patients with chronic kidney disease with Sofosbuvir-basead regimes
por: Rossato, Giovana, et al.
Publicado: (2019)

Opium Use and Cancer Risk: A Comprehensive Systematic Review and Meta-Analysis of Observational Studies
por: Mansouri, Masoume, et al.
Publicado: (2022)

Use of sofosbuvir in chronic kidney disease: Is it necessary?
por: Lim, Tae Seop, et al.
Publicado: (2017)

Successful Treatment of Hepatitis C with Simeprevir, Sofosbuvir, and Ribavirin in an HIV Coinfected Liver Transplant Patient with Advanced Chronic Kidney Disease
por: Maruyama, Anna, et al.
Publicado: (2016)

Patient-reported Outcomes in Asian Patients With Chronic Hepatitis C Treated With Ledipasvir and Sofosbuvir
por: Younossi, Zobair M., et al.
Publicado: (2016)

Rapid virological&End treatment response of patients treated with Sofosbuvir in Chronic Hepatitis C
por: Siddique, Muhammad Shoaib, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_m8mshfh9g6a8r3amabf43sv6on